Kryxana 200 mg Tablet
  1. Home
  2. Pharma Products
  3. Sandoz Private Limited
  4. Kryxana 200 mg Tablet

Kryxana 200 mg Tablet

Kryxana 200 mg Tablet contains ribociclib 200 mg, a cyclin-dependent kinase 4/6 inhibitor used as an anticancer medicine. It is used for hormone receptor-positive, HER2-negative advanced or metastatic breast cancer in combination with appropriate endocrine therapy. The medicine is prescription-only and should be taken under the supervision of an oncologist.

BUY NOW

Category

Ribociclib works by inhibiting CDK4 and CDK6, proteins involved in the progression of cancer cells through the cell cycle. Kryxana is used with an aromatase inhibitor or fulvestrant in specific breast cancer treatment regimens. The standard regimen described in the Indian prescribing information is 600 mg once daily for 21 consecutive days followed by 7 days without treatment in a 28-day cycle. Regular medical monitoring may be required during treatment because ribociclib can affect blood counts, liver function, and cardiac electrical activity.

Technical Specification

Specification Details
Active Ingredient Ribociclib
Strength 200 mg
Dosage Form Film-coated Tablet
Therapeutic Class CDK4/6 Inhibitor
Pack Size 21 tablets
Marketer Novartis India Ltd

Product Also Known As

Kryxana 200 mg Tablet, Kryxana 200mg Tablet, Ribociclib 200 mg Tablet, Ribociclib 200mg Tablet, Ribociclib Film-Coated Tablet, Ribociclib Breast Cancer Tablet, CDK4/6 Inhibitor Tablet